Association of High-Density Lipoprotein Cholesterol With Cognitive Function: Findings From the PROspective Study of Pravastatin in the Elderly at Risk. (27th May 2020)

• Record Type: Journal Article
• Authors: Grasset, Leslie; Smit, Roelof A. J.; Caunca, Michelle R.; Elfassy, Tali; Odden, Michelle C.; van der Grond, Jeroen; van Buchem, Mark A.; Stott, David J.; Sattar, Naveed; Trompet, Stella; Jukema, J. Wouter; Zeki Al Hazzouri, Adina
• Is Part Of: Journal of aging and health. Volume 32:Number 9(2020)
• Page Start: 1267
• Page End: 1274
• Publication Date: 2020-05-27
• Subjects: cognition -- homeostasis -- lipid -- variability -- vascular; Older people -- Health and hygiene -- Periodicals; Geriatrics -- Periodicals; 618.97
• DOI: 10.1177/0898264320916959
• Languages: English
• ISSNs: 0898-2643

Abstract

Objective: We aimed to examine whether variability in high-density lipoprotein cholesterol (HDL-c) over time was associated with cognitive function.Method: We conducted a post hoc analysis of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) trial. Our sample included 4, 428 participants with at least two repeated HDL-c measures between Months 3 and 24 postbaseline and with cognitive assessments at Month 30. HDL-c variability was defined as the intraindividual standard deviation over each person's repeated measurements.Results: Higher HDL-c variability was associated with worse performance on the Letter-Digit Coding Test (β [95% confidence interval] [CI] = −4.39 [−7.36, −1.43], p = .004), immediate recall on the 15-Picture Learning Test (β [95% CI] = −0.98 [−1.86, −0.11], p = .027), and delayed recall on the 15-Picture Learning Test (β [95% CI] = −1.90 [−3.14, −0.67], p = .002). The associations did not vary by treatment group.Discussion: Our findings suggest that variability in HDL-c may be associated with poor cognitive function among older adults.